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Background: Recommendations regarding evaluation and manage-
ment of eosinophilic esophagitis (EoE) remain incompletely deﬁned.
This survey assesses: how providers across the world diagnose,
evaluate, and treat EoE and how educational activities affect
management.
Methods: A web-based survey was sent to the members of World
Allergy Organization, American College of Allergy, Asthma, and
Immunology, and American Academy of Allergy, Asthma, and
Immunology. A x2 analysis compared responses based on personal
and practice demographics and participation in educational activities.
Results: Of the 200 respondents, 68.5% were from the United
States. The majority were allergists, who require biopsy to diagnose
EoE, perform allergy testing, and obtain follow-up biopsy after
treatment. The following variables had signiﬁcant differences: (1)
US practitioners were more likely to test for immediate-type
hypersensitivity to foods and obtain follow-up endoscopic biopsies
after the initial treatment; (2) Practitioners encountering patients with
EoE more frequently were more likely to ask about personal and
family history of atopy, test for immediate-type hypersensitivity to
aeroallergens and foods, and recommend follow-up biopsy after
treatment; and (3) Practitioners who participate more often in EoE
workshops were more likely to perform patch testing for foods,
while attendance at EoE lectures increased EoE management
conﬁdence.
Conclusions: Diagnostic and management strategies differ based on
practice location, EoE patient load, and participation in educational
activities. Practitioners who attend more EoE lectures are more
conﬁdent managing EoE.
Key Words: eosinophilic esophagitis, evaluation, treatment,
educational activities, international, survey
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Eosinophilic esophagitis (EoE) is a chronic, clinicopatho-logic inﬂammatory disease process with an increasing
prevalence.1,2 The prevalence of EoE has been estimated to
be 52 per 100,000 patients in the general population and 2.8%
of symptomatic patients with dysphagia.3,4 EoE has been
shown to be associated with an impaired quality of life and
increased risk of food impaction.5 Criteria for diagnosis
established in the 2007 consensus recommendations were
further reﬁned in the 2011 update to the consensus recom-
mendations. The new recommendations establish the nomen-
clature of EoE and the concept of chronic eosinophilic
inﬂammation. Although the ﬁndings of $15 eosinophils per
high-power ﬁeld on esophageal biopsy as a diagnostic
criterion remain unchanged, the importance of considering
the clinical symptoms and other pathologic ﬁndings are
emphasized.2
The recommendations regarding allergic work-up and
management are still incompletely deﬁned. Testing for
immediate-type hypersensitivity reactions to aeroallergens
has been recommended since 2007 based on studies demon-
strating that pulmonary exposure to aeroallergens induces
EoE and epithelial hyperplasia.6–15 Skin prick testing (SPT)
for foods to identify potential allergens has been recommen-
ded since the initial publication as well.6,16 Combination of
SPT and atopy patch testing (APT) for foods to increase the
identiﬁcation of food allergies has been suggested by author-
ities in the ﬁeld.17,18 This combination has been shown to
have a high negative predictive value (except to milk) and
a good positive predictive value to identify the potential foods
responsible for symptoms of EoE.19 The consensus recom-
mendations support dietary therapy by means of elimination
diet (antigen removal) or elemental diet (amino acid-based
formula) for children but do not provide speciﬁc recommen-
dations for adults.2,6 There has been no clear guidance on
whether the elimination diet should be empiric (based on
the most common food allergens) or based on SPT and
APT results.2,6
Elimination diets, based on combined results of SPT
and APT, or empiric removal of the 6 most common food
allergens from the diet, both resulted in a resolution of
symptoms in roughly 75% of subjects.20–22 Both strategies
also signiﬁcantly improved esophageal histology, including
inﬂammation and eosinophil levels.21–23 An elemental diet
similarly resulted in normalization of esophageal eosinophil
levels but was more efﬁcacious in alleviating esophageal
symptoms than elimination diets.24–26 In fact, elemental diets
resulted in cessation of symptoms in more than 95% of
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patients, suggesting food allergy as a causative agent for
EoE.24 Elemental diets are not preferred, however, because
of their adverse effect on quality of life and increased cost.
There are no recommendations on whether dietary therapy
should be attempted before medical therapy.
Regarding medical treatment, evidence exists for several
therapeutic interventions. Proton pump inhibitors (PPIs) are
commonly used early in the disease course, often before EoE
diagnosis, to treat symptoms suggestive of gastroesophageal
reﬂux disease (GERD). They may also be used to treat
concomitant GERD, to fulﬁll the diagnostic criteria by ruling
out GERD as the cause of symptoms,6 or to assess for and treat
PPI-responsive esophageal eosinophilia.2 A growing body of
literature supports the use of topical swallowed steroids not
only to control symptoms but also to improve histologic ﬁnd-
ings.27–38 However, guidelines on treatment end points and
maintenance medical therapy are lacking. Therapeutic use of
cromolyn, leukotriene antagonists,39 and systemic corticoste-
roids (except during severe, acute events) are not recommen-
ded because of lack of efﬁcacy or side effects.2,6
There is no clear professional guideline on the frequency
of monitoring esophageal histopathology in EoE patients. After
diagnosis, repeating esophagogastroduodenoscopy with changes
in symptoms, at 4 or more weeks after a change in treatment or
after a period of treatment noncompliance, have been proposed.2
However, without a clear knowledge of the natural course or
possible complications of long-term untreated or undertreated
EoE, clinical practice likely remains highly individualized.
Given the recent discovery of this disease entity, the
variety of approaches to management, the amount of
emerging evidence, and the number of unanswered questions,
the management of EoE assumedly varies among practi-
tioners. This assertion is supported by surveys of allergists
and gastroenterologists in the United States that revealed
variability in diagnostic criteria and treatment approach.3,40
The purpose of our study was to assess how providers across
the world diagnose, evaluate, and treat patients with EoE and
how education affects their approach to patients with EoE.
METHODS
This cross-sectional study of evaluation and management
practices of physicians caring for patients with EoE was
performed in survey format. The study was approved by the
Institutional Review Board of the Pennsylvania State University
College of Medicine/Penn State Hershey Medical Center. A
link to a web-based survey was distributed to members of the
World Allergy Organization, the American College of Allergy,
Asthma, and Immunology, and the American Academy of
Allergy, Asthma, and Immunology. Participation was by
invitation only, restricted to members of the aforementioned
organizations. It was not otherwise limited geographically. The
survey remained open from October 2010 to January 2011 to
allow sufﬁcient time for an adequate number of responses.
The survey consisted of 24 questions. Basic demo-
graphic data included the country of medical practice, gender,
primary specialty, subspecialty (if any), number of years in
practice, setting of practice (academic or private), practice
location (urban/suburban or rural), and number of patients
seen per week. Practice-related demographic data speciﬁc to
EoE included frequency of encounters (daily, weekly, or
monthly) with EoE patients, average number of encounters
with EoE patients per week, and the most common age-group
encountered in patients with EoE.
Other questions focused on the diagnostic evaluation of
patients with EoE. Respondents were asked if they think
esophageal biopsy is required for diagnosis, how often they
ask about personal and/or family history of atopy, how
frequently they perform allergy testing in EoE patients, and
which types of hypersensitivity testing are offered.
There were several questions focused on therapeutic
management of EoE. Respondents were asked how often EoE
patients are on PPIs at their initial visit, their choice of initial
therapy, and second-line therapy. They were also asked
whether they recommend a follow-up biopsy after initiation
of treatment.
Questions related to education about EoE included the
number of lectures and workshops on EoE attended by the
physician in the previous 3 years. Moreover, questions about
the type of the workshops attended (including, patch testing
for foods, elemental diets, food elimination diets, and food
allergy), the physician’s degree of conﬁdence in management
of EoE, and whether there is a perceived need for further
education about EoE were included. Should there be a per-
ceived need for further education, there was a question about
the most beneﬁcial education format.
Chi-square analysis was used to compare responses
with the questions according to the following independent
variables: country of practice, gender, specialty, years in
practice, type of practice, location of practice, number of
patients seen with EoE, frequency of EoE patients seen,
number of lectures, and number of workshops on EoE
attended.
RESULTS
The survey was sent to 2000 individuals. There were
200 respondents to the survey, 137 (68.5%) of whom were
from the United States (Table 1). All 6 inhabited continents
and 33 countries were represented. After the United States,
practitioners from Europe participated the most in the survey,
including representatives from Spain (5); Italy (4); the United
Kingdom (3); Iceland and Greece (2 each); Austria, Belgium,
the Netherlands, Portugal, Slovenia, Sweden, and Switzerland
(1 each). Australia was represented twice. The characteristics
of respondents are shown in Table 1.
Nearly half of participants responded that they are
practicing in an academic setting and have been in practice for
more than 10 years. As for medical specialties, 48% of
respondents were trained in pediatrics, 30% in medicine, 11%
in combined medicine/pediatrics programs, and 11% listed
other specialties, many of which were described as allergy,
allergy/immunology, or allergology. This reﬂects the fact that
in many countries other than the United States, allergy/
allergology is a primary specialty. When respondents identi-
ﬁed a subspecialty, they included allergy and immunology
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(86%), allergy only (11%), gastroenterology, pulmonology,
and allergology.
Regarding patient volume, more than two thirds of
respondents (67.5%) see more than 30 patients per week.
Frequency of encountering patients with EoE was variable.
While 27% of respondents encounter EoE patients on a daily
to weekly basis, 73% only encounter them monthly or every
few months. Seventeen percent of respondents see more than
1 EoE patient per week, while 6% see more than 3. The
majority of respondents report that the most common age
group of EoE patients they encounter is younger than 30
years, with 38% being in the ﬁrst decade of life. Only 22%
report that the most common age of EoE patients they see is
older than 30 years.
The overwhelming majority (97%) responded that
esophageal biopsy is required to diagnose EoE, and the same
amount do ask about a personal and family history of atopy
(Fig. 1). In addition, 96% of respondents usually or always
recommend allergy evaluation via testing. As for the type of
allergy testing, 68% recommend testing for immediate-type
hypersensitivity to aeroallergens and 87% recommend such
testing for foods. However, the minority (44%) recommend
testing for delayed-type hypersensitivity via patch testing for
foods. The majority (65%) responded that they do recom-
mend a follow-up biopsy after the initial therapy.
Most respondents (85%) reported that their patients are on
PPIs at initial presentation. The initial therapy prescribed by the
respondents was quite variable (Fig. 2). One third of
respondents reported starting with swallowed aerosolized ste-
roid, such as ﬂuticasone, budesonide, or beclomethasone.
Others start treatment with a PPI (29%) or an elimination diet
(25%). Systemic corticosteroids, montelukast, and elemental
diet (amino acid-based formulas) were the initial therapy offered
by only 3% of respondents. The second-line therapy recommen-
ded by respondents was also variable. While 40% use elimina-
tion diet, 21% use PPIs, 12% use elemental diet, and 11% use
swallowed aerosolized steroids as second-line therapy.
Most respondents (91%) reported attending at least one
lecture on EoE within the past 3 years (Fig. 3). This includes
the 58% of respondents who reported attending 3 or more EoE
lectures in this time frame. Meanwhile, 65% attended at least
one workshop on EoE and one third of respondents attended
multiple. Of these, 35% of respondents speciﬁcally attended
a workshop involving patch testing for foods. Additionally,
19% attended a workshop on elemental diets, and one third
attended a workshop on food elimination diets. Workshops on
food allergies were attended by 59% of respondents.
Only one fourth of respondents felt completely conﬁ-
dent in their ability to manage EoE. Although two thirds of
respondents felt somewhat conﬁdent, 8% were not at all
conﬁdent in their management ability. More than 95% of
respondents felt a perceived need for further education
regarding EoE. Opinions were mixed regarding the preferred
format for the further education. While 48% preferred
a workshop, 41% preferred a lecture.
When comparing respondents from the United States
versus international practitioners, US practitioners recom-
mend follow-up biopsy more frequently (69 vs 50%,
P ¼ 0.011). US practitioners also recommend immediate-type
hypersensitivity to foods more frequently (91 vs 76%,
P ¼ 0.01). There were no signiﬁcant differences between
genders. Similarly, the number of years in practice did not
signiﬁcantly alter any practice patterns.
Comparing primary specialties, pediatricians were less
likely to test for immediate-type hypersensitivity reactions to
food (80 vs 96%, P ¼ 0.02). Practitioners in private practice
were more likely to recommend testing for immediate hyper-
sensitivity reactions to food (92 vs 81%, P ¼ 0.03). There
was a trend toward performing patch testing for foods among
practitioners in rural compared with urban/suburban areas
(73 vs 42%, P ¼ 0.06). No differences were seen when strat-
ifying by overall patient volume.
Practitioners who see EoE patients more frequently are
more likely to ask about a personal or family history of atopy.
They are also more likely to test for immediate-type
hypersensitivity to aeroallergens (80 vs 53%, P ¼ 0.003)
and foods (97 vs 82%, P ¼ 0.05). Furthermore, those seeing
more EoE patients per week are more likely to check
TABLE 1. Background Characteristics of Survey Respondents
Characteristics Number Percent
Country (n ¼ 200)
USA 137 68.5
Non-USA 63 31.5
Gender (n ¼ 195)
Male 105 54
Female 90 46





Subspecialty (n ¼ 194)
Allergy–immunology 166 86
Allergy only 22 11
Other 6 3
Years in practice (n ¼ 200)
.10 105 52.5
#10 95 47.5
Type of practice (n ¼ 185)
Academic 96 52
Private 89 48
Location of practice (n ¼ 194)
Urban/suburban 183 94
Rural 11 6
Patients seen per week (n ¼ 200)
.30 135 67.5
#30 65 32.5
EoE patient encounter frequency (n ¼ 197)
Monthly 144 73
Weekly 53 27
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a follow-up biopsy after initiating treatment (75 vs 54%,
P ¼ 0.04). Those practitioners who see more EoE patients
tended to be more conﬁdent managing EoE (100 vs 85%,
P ¼ 0.07), although this missed statistical signiﬁcance.
Several differences were seen based on education.
Those who attended more lectures were more likely to ask
about family or personal history of atopy (98 vs 81%,
P ¼ 0.009) and to recommend a follow-up biopsy (74 vs
62%, P ¼ 0.003). Those who attended more lectures were also
more likely to test for immediate hypersensitivity to foods,
although this missed signiﬁcance (92 vs 76%, P ¼ 0.08). More
EoE lecture attendance correlated to greater conﬁdence in
personal ability to manage EoE (97 vs 76%, P ¼ 0.004) as
depicted in Figure 4. Similarly, those with greater attendance
at an EoE workshop were more conﬁdent, but this missed
statistical signiﬁcance (96 vs 87%, P ¼ 0.19). Greater work-
shop attendance was correlated with an increased likelihood of
performing patch testing for foods (61 vs 33%, P ¼ 0.01) and
recommending a follow-up biopsy (82 vs 64%, P ¼ 0.01) as
shown in Figure 5.
DISCUSSION
Our survey reveals that allergists worldwide are
involved in the evaluation and management of patients with
EoE. It also demonstrates that, for the most part, allergists are
following the best available evidence, with practice variability
lying in certain areas that need further clariﬁcation, particu-
larly treatment strategies.
Care of the EoE patient is a multidisciplinary venture
involving different specialties. The role of allergists is
particularly important in evaluation and management of
patients with this chronic inﬂammatory disease. In 2007,
a panel of experts developed consensus recommendations
related to EoE. More recently, in July 2011, an update of the
recommendations was generated, which clariﬁed certain areas
regarding the general concept of this disease process and the
recommendations based on the evidence from the advancing
literature in the ﬁeld. This survey likely reﬂects the impact of
the 2007 recommendations on the allergy practices. The
growing educational activities related to EoE in the past few
years may have also affected the practice patterns.
FIGURE 1. Responses regarding EoE
evaluation.
FIGURE 2. Responses regarding EoE treatment. FIGURE 3. Responses regarding EoE education.
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Practitioners from the United States constituted the
majority of respondents to this survey, followed by practi-
tioners from Europe. This may reﬂect better access to the
survey by these practitioners. It may also show predilection of
EoE among individuals in industrialized countries. Surpris-
ingly, we did not have any respondents from Canada
compared with the survey conducted by Spergel et al.3
The authors realize that because of small number of
participants from outside the United States in this survey, it is
difﬁcult to compare the practice patterns of the US with non-
US practitioners. Although we are aware of this, we found
differences that are worth considering. Based on this survey,
US practitioners are more likely to recommend allergy
evaluation by testing for immediate-type hypersensitivity
reactions to foods. This ﬁnding could suggest that compared
with other countries, US allergists are more likely to consider
food allergens as the potential pathogenic factor. Because the
current guidelines encourage practitioners to test for imme-
diate-type hypersensitivity reactions to foods, this may also
reﬂect the access to the recommendations and educational
activities. However, one may argue that it could simply reﬂect
the difference in reimbursement methods or allocation of
resources in the United States compared with other countries.
US practitioners are also more likely to recommend
follow-up biopsy after initial treatment. This may reﬂect
increased access to practitioners capable of performing EGD
with biopsy in the United States. There are suggestions but no
clearly established guideline for follow-up biopsy in the
consensus recommendations. Therefore, it could be secondary
to recommendations during educational activities regarding
these practices. Alternatively, the differences may be related
to general differences in the culture of medical practice
between the United States and other countries. For instance,
a more readily available consultation services in the United
States may contribute to this ﬁnding.
Two aspects of the practices that affected the approach
to the patients were frequency and the number of patients
seen with EoE. Practitioners who encounter EoE patients
more frequently are more likely to recommend tests for
immediate-type hypersensitivity reactions to foods and aero-
allergens and to recommend follow-up biopsies after treat-
ment. This may be explained by involvement in more
educational activities by those who see more patients.
Alternatively, those with fewer EoE encounters may have
not yet developed a standard approach to the EoE patient
because of a paucity of experience.
With regard to the treatment options for EoE, our
results are comparable with the results of a larger survey
conducted by Spergel et al.3 The variability seen in the pre-
ferred ﬁrst-line agent of the respondents is most likely
because of the lack of a standardized treatment algorithm in
the management of EoE. At the present time, a standard algo-
rithm would be difﬁcult, if not impossible, to create because
of the lack of well-designed trials comparing different treat-
ments. The majority of controlled trials involve comparing
one steroid regimen versus another. Randomized controlled
trials comparing different treatment modalities would be
greatly beneﬁcial in guiding ﬁrst-line preferences and would
certainly lend themselves to development of a more estab-
lished algorithm or formal consensus recommendations.
On their large-scale survey, Spergel et al3 reported that
only a minority of all practitioners adhere to the consensus
diagnostic criteria. On a survey of gastroenterologists, Peery
et al40 also found that only minority of gastroenterologists
FIGURE 4. Association between
attending lectures and practice
patterns.
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follow the recommended diagnostic criteria. Our survey
focused on the screening for atopy by obtaining history and
testing for sensitization to allergens; however, we did not
speciﬁcally ask about the diagnostic criteria being used. Sper-
gel et al3 reported that the younger practitioners were more
likely to adhere to the diagnostic criteria. Our survey did not
reveal signiﬁcant practice pattern differences when stratiﬁed
by the years in practice, but again we did not speciﬁcally
inquire about the diagnostic criteria being used.
Several differences are seen in the practice patterns of
those who have attended educational sessions. Practitioners
who attended more lectures were more likely to inquire about
personal or family history of atopy, recommend testing for
immediate-type hypersensitivity to foods and aeroallergens,
and request follow-up biopsies after initial treatment. These
individuals also feel more conﬁdent managing patients with
EoE. Additionally, those who attended workshops were more
likely to perform APT. The mere presence of signiﬁcant
differences in practice patterns based on educational activities
demonstrates their effectiveness and inﬂuence on physician
practice. These differences may also imply that the manage-
ment recommendations that practitioners receive at such
activities either are clearer or more complete than the
published guidelines. Future surveys directly asking whether
the respondents are completely familiar with the contents of
the most recent consensus recommendations along with
inquiry into educational activity participation may provide
stronger insight into this ﬁnding.
Some of the speciﬁc differences seen based on the
participation in educational activities reside in areas that were
not deﬁnitively addressed in the 2007 consensus recommen-
dations. For instance, the higher rate of recommending APT
among those who more often participate in workshops needs
particular attention. The 2007 consensus recommendations
recognized the success of the combination of SPT and APT in
identifying the potential foods responsible for symptoms but
recommended against its use until further data are available.
The 2011 consensus recommendations make no further direct
recommendations regarding APT, whether it should be used
for elimination diet or for other purposes. Greater workshop
attendance also correlated to recommending follow-up biop-
sies after initiating treatment, which is another topic on which
the recommendations are less than deﬁnitive. This suggests
another area of discordance between the published recom-
mendations and teachings at educational activities.
The trend toward increased conﬁdence managing EoE
patients among those having attended more workshops and
lectures is not surprising. Whether it is because of an increase
in the quality or simply an increase in quantity (repetition and
reafﬁrmation) of their EoE education cannot be interpreted
based on the survey data.
Most respondents to the survey agreed that there is
a need for increased education. However, most also felt at
least somewhat, if not completely, conﬁdent in managing EoE
patients. This may be interpreted as a conﬁdence in one’s
management ability based on available evidence and
FIGURE 5. Association between
attending workshops and practice
patterns.
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recommendations but a concomitant perceived need for fur-
ther studies with subsequent education and/or strengthened
consensus guidelines.
Our survey has several limitations. The majority of
respondents were allergy practitioners from the United States,
while the second-most represented country had only 5
respondents. This limited the study in its ability to compare
the United States to any particular country or geographic area.
However, the variety of other nations represented allowed for
a very heterogeneous comparison group, thereby improving
generalizability. The survey format of this study lends itself to
response bias. Therefore, there is the possibility that only
those practitioners who have a strong interest in EoE
responded to the survey. However, 40% of respondents
reported only encountering an EoE patient every few months.
As these physicians lacked a signiﬁcant cohort of EoE
patients, it can be assumed that the respondents were not
limited to practitioners with a strong interest in EoE.
A survey sent to the gastrointestinal societies along
with allergy societies to compare various aspects of diagnosis,
follow-up, and management between gastroenterologists
and allergists-immunologists will be worthwhile. Moreover,
language-speciﬁc surveys for the non–English speaking prac-
titioners across the globe will be extremely useful to compare
the variation in practice patterns.
In summary, although the prevalence of EoE is rising,
our knowledge of optimal management practices is incom-
plete. There is a degree of variability regarding EoE
management in clinical practice, most notably when compar-
ing practitioners who are stratiﬁed based on either the
frequency with which they see EoE patients or their involve-
ment in educational activities, such as lectures or workshops.
The most striking differences between practitioners fall in the
best treatment strategy. Future research studies directly
comparing different treatment modalities, and research into
treatments targeting speciﬁc receptors or molecules, will be
promising.
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